v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
At-the-Market Offering
Underwritten offering
Common Shares
Common Shares
At-the-Market Offering
Common Shares
Underwritten offering
Common Shares
Pre-Funded Warrant
Treasury Stock
Capital in Excess of Par Value
Capital in Excess of Par Value
At-the-Market Offering
Capital in Excess of Par Value
Underwritten offering
Accumulated Other Comprehensive Income/(Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024       12,385,001                  
Beginning balance at Dec. 31, 2024 $ 60,737     $ 1       $ (3,000) $ 3,659,885     $ 61 $ (3,596,210)
Beginning balance (in shares) at Dec. 31, 2024               552,307          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Shares issued under equity compensation plans (in shares)       21,709                  
Shares issued under equity compensation plans 7               7        
Stock-based compensation 3,898               3,898        
Comprehensive income (loss) (50,904)                     (22) (50,882)
Ending balance (in shares) at Mar. 31, 2025       12,406,710                  
Ending balance at Mar. 31, 2025 13,738     $ 1       $ (3,000) 3,663,790     (39) (3,647,092)
Ending balance (in shares) at Mar. 31, 2025               552,307          
Beginning balance (in shares) at Dec. 31, 2024       12,385,001                  
Beginning balance at Dec. 31, 2024 60,737     $ 1       $ (3,000) 3,659,885     61 (3,596,210)
Beginning balance (in shares) at Dec. 31, 2024               552,307          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Comprehensive income (loss) (92,550)                        
Ending balance (in shares) at Jun. 30, 2025       12,457,252                  
Ending balance at Jun. 30, 2025 (24,211)     $ 1       $ (3,000) 3,667,487     (14) (3,688,685)
Ending balance (in shares) at Jun. 30, 2025               552,307          
Beginning balance (in shares) at Mar. 31, 2025       12,406,710                  
Beginning balance at Mar. 31, 2025 13,738     $ 1       $ (3,000) 3,663,790     (39) (3,647,092)
Beginning balance (in shares) at Mar. 31, 2025               552,307          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Shares issued under equity compensation plans (in shares)       50,542                  
Shares issued under equity compensation plans 211               211        
Stock-based compensation 3,486               3,486        
Comprehensive income (loss) (41,646)                     (53) (41,593)
Ending balance (in shares) at Jun. 30, 2025       12,457,252                  
Ending balance at Jun. 30, 2025 $ (24,211)     $ 1       $ (3,000) 3,667,487     (14) (3,688,685)
Ending balance (in shares) at Jun. 30, 2025               552,307          
Beginning balance (in shares) at Dec. 31, 2025 20,378,832     20,378,832                  
Beginning balance at Dec. 31, 2025 $ 89,832     $ 2         3,850,099     17 (3,760,286)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Shares issued under equity compensation plans (in shares)       130,034                  
Shares issued under equity compensation plans 4,055               4,055        
Stock-based compensation 3,355               3,355        
Shares issued under offering, net of underwriting discounts and offering costs (in shares)         1,325,295                
Shares issued under offering, net of underwriting discounts and offering costs   $ 93,063               $ 93,063      
Shares and pre-funded warrant issued during period (in shares)           7,637,931,000              
Shares and pre-funded warrant issued during period (in amount)     $ 431,866     $ 1         $ 431,865    
Comprehensive income (loss) (45,955)                     (1,051) (44,904)
Ending balance (in shares) at Mar. 31, 2026       29,472,092                  
Ending balance at Mar. 31, 2026 $ 576,216     $ 3         4,382,437     (1,034) (3,805,190)
Beginning balance (in shares) at Dec. 31, 2025 20,378,832     20,378,832                  
Beginning balance at Dec. 31, 2025 $ 89,832     $ 2         3,850,099     17 (3,760,286)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Comprehensive income (loss) $ (87,299)                        
Ending balance (in shares) at Jun. 30, 2026 20,378,832     34,129,664                  
Ending balance at Jun. 30, 2026 $ 903,121     $ 3         4,750,686     (1,756) (3,845,812)
Beginning balance (in shares) at Mar. 31, 2026       29,472,092                  
Beginning balance at Mar. 31, 2026 576,216     $ 3         4,382,437     (1,034) (3,805,190)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Shares issued under equity compensation plans (in shares)       94,417                  
Shares issued under equity compensation plans 878               878        
Stock-based compensation 3,365               3,365        
Shares issued under offering, net of underwriting discounts and offering costs (in shares)         207,555 4,062,500 293,100            
Shares issued under offering, net of underwriting discounts and offering costs   $ 13,580 $ 350,426             $ 13,580 $ 350,426    
Comprehensive income (loss) $ (41,344)                     (722) (40,622)
Ending balance (in shares) at Jun. 30, 2026 20,378,832     34,129,664                  
Ending balance at Jun. 30, 2026 $ 903,121     $ 3         $ 4,750,686     $ (1,756) $ (3,845,812)